Comprehensive Analysis of Long Noncoding RNAs and Messenger RNAs Expression Profiles in Patients with Marjolin Ulcer

Background Marjolin ulcer (MU) is an aggressive cutaneous malignancy. Typically, MU occurs over a period of time in post-burn and/or post-traumatic lesions and scars. However, the pathogenesis of scar carcinogenesis and MU development remains to be elucidated. The present study aimed to investigate the long noncoding RNA (lncRNA) and messenger RNA (mRNA) expression profiling in MU, which could provide new information on the potential molecular mechanisms of MU development. Material/Methods The lncRNA microarray analysis was conducted in normal skin, scar, and MU tissue, and quantitative real-time PCR experiment was carried out to validate the reliability of the microarray data. Furthermore, a series of integrative bioinformatic approaches were applied to decipher the function of differentially expressed lncRNAs. Results A total of 7130 lncRNAs and 9867 mRNAs were differentially expressed among normal skin, scar, and MU tissues. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that these aberrantly expressed transcripts were mainly involved in cell cycle, immune response, and the p53 signaling pathway. Series Test of Cluster analysis indicated certain dysregulated lncRNAs were expressed with a gradually increasing or decreasing trend and might participated in malignant transformation of scar tissue postburn. Co-expression analysis showed 5 selected lncRNAs might regulate cell proliferation through the p53 signaling pathway. Finally, the competing endogenous RNA (ceRNA) network indicated that lncRNA uc001oou.3 might be implicated in ceRNA mechanism during MU development. Conclusions Taken together, our study implied the aberrant expression of lncRNAs may play an important role in the pathogenesis and development of MU, and the exact mechanism warrants further investigation.

[1]  D. Ye,et al.  Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus. , 2017, Cellular immunology.

[2]  Beiyun Xu,et al.  A genome-wide association scan of biological processes involved in oral lichen planus and oral squamous cell carcinoma , 2017, Medicine.

[3]  E. Herter,et al.  Non-Coding RNAs: New Players in Skin Wound Healing , 2017, Advances in wound care.

[4]  Jun Li,et al.  The Long Non-Coding RNA LncRNA8975-1 is Upregulated in Hypertrophic Scar Fibroblasts and Controls Collagen Expression , 2016, Cellular Physiology and Biochemistry.

[5]  H. Eguchi,et al.  CKAP4 is a Dickkopf1 receptor and is involved in tumor progression. , 2016, The Journal of clinical investigation.

[6]  Lin Jiang,et al.  High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma , 2016, Cancer Chemotherapy and Pharmacology.

[7]  T. Gambichler,et al.  Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma. , 2016, Epigenomics.

[8]  J. Xu,et al.  Differentially expressed lncRNAs and mRNAs identified by microarray analysis in GBS patients vs healthy controls , 2016, Scientific Reports.

[9]  Wang Ma,et al.  ceRNA in cancer: possible functions and clinical implications , 2015, Journal of Medical Genetics.

[10]  M. Yao,et al.  Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt , 2015, Clinical Cancer Research.

[11]  I. Kurochkin,et al.  Long noncoding RNAs: a potential novel class of cancer biomarkers , 2015, Front. Genet..

[12]  Hua Zhu,et al.  Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway , 2015, Cellular Physiology and Biochemistry.

[13]  Amanda B. Spurdle,et al.  A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. , 2015, Endocrine-related cancer.

[14]  Lin Xu,et al.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma , 2015, Tumor Biology.

[15]  M. Saaiq,et al.  Marjolin's ulcers in the post-burned lesions and scars. , 2014, World journal of clinical cases.

[16]  S. Dhanasekaran,et al.  The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer , 2014, Molecular Cancer Research.

[17]  Kevin C. Wang,et al.  Long noncoding RNA: significance and potential in skin biology. , 2014, Cold Spring Harbor perspectives in medicine.

[18]  Ji-Hee Kim,et al.  Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma. , 2013, International journal of oncology.

[19]  Y. Pilpel,et al.  miR-661 downregulates both Mdm2 and Mdm4 to activate p53 , 2013, Cell Death and Differentiation.

[20]  Pier Paolo Pandolfi,et al.  ceRNA cross-talk in cancer: when ce-bling rivalries go awry. , 2013, Cancer discovery.

[21]  R. Simpson,et al.  Can exercise-related improvements in immunity influence cancer prevention and prognosis in the elderly? , 2013, Maturitas.

[22]  Tsuyoshi Saito,et al.  p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1 , 2013, Virchows Archiv.

[23]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[24]  Ruedi Aebersold,et al.  Protein expression changes in ovarian cancer during the transition from benign to malignant. , 2012, Journal of proteome research.

[25]  Q. Wei,et al.  Modifying effect of MDM4 variants on risk of HPV16‐associated squamous cell carcinoma of oropharynx , 2012, Cancer.

[26]  J. Gilyoma,et al.  Marjolin's ulcers at a university teaching hospital in Northwestern Tanzania: a retrospective review of 56 cases , 2012, World Journal of Surgical Oncology.

[27]  A. Green,et al.  Skin Cancer Arising in Scars: A Systematic Review , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[28]  John S Mattick,et al.  Long noncoding RNAs in cell biology. , 2011, Seminars in cell & developmental biology.

[29]  P. Nthumba Marjolin's ulcers: theories, prognostic factors and their peculiarities in spina bifida patients , 2010, World journal of surgical oncology.

[30]  Jui-yung Yang,et al.  Burn scar carcinoma , 2010, The Journal of dermatological treatment.

[31]  S. Kuvat,et al.  Current Concepts in the Management of Marjolin's Ulcers: Outcomes From a Standardized Treatment Protocol in 16 Cases , 2010, Journal of burn care & research : official publication of the American Burn Association.

[32]  S. Agale,et al.  Marjolin's ulcer--a diagnostic dilemma. , 2009, The Journal of the Association of Physicians of India.

[33]  E. Çopcu,et al.  Marjolin's ulcer: a preventable complication of burns? , 2009, Plastic and reconstructive surgery.

[34]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[35]  A. Kılıç,et al.  Squamous Cell Carcinoma Developing on Burn Scar , 2006, Annals of plastic surgery.

[36]  A. Kowal-Vern,et al.  Burn scar neoplasms: a literature review and statistical analysis. , 2005, Burns : journal of the International Society for Burn Injuries.

[37]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[38]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[39]  H. Kuwano,et al.  TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma , 2014, Annals of Surgical Oncology.

[40]  黒川 貴則 Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage , 2004 .